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Since the dawn of the post-genomic era a myriad of novel high-throughput technologies
have been developed that are capable of measuring thousands of biological molecules at
once, giving rise to various “omics” platforms.These advances offer the unique opportunity
to study how individual parts of a biological system work together to produce emerging
phenotypes.Today, many research laboratories are moving toward applying multiple omics
platforms to analyze the same biological samples. In addition, network information of inter-
acting molecules is being incorporated more and more into the analysis and interpretation
of these multiple omics datasets, which provides novel ways to integrate multiple layers of
heterogeneousbiologicalinformationintoasinglecoherentpicture.Here,weprovideaper-
spective on how such recent “integrative omics” efforts are likely going to shift biological
paradigms once again, and what challenges lie ahead.
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INTRODUCTION
The ﬁrst generation of whole-genome sequencing projects have
inspired the development of technologies aimed at comprehen-
sively characterizing various types of biological molecules, open-
ing up entirely new ﬁelds such as genomics,transcriptomics,pro-
teomics, metabolomics, and so forth. Thanks to these technolog-
ical advances, one can now routinely sequence the entire genome
of an organism to scan for genetic polymorphisms, measure the
abundance of genes and their products, map epigenetic modiﬁ-
cations and transcriptional regulations, chart the global networks
of genetic interactions or protein–protein interactions (PPI), and
comprehensively measure sugars, lipids, and metabolites in vir-
tually any biological specimen. The systems-level information
provided by each omics platform offers a unique insight into the
complexity of a biological system and,as a consequence,scientiﬁc
discoveries and their clinical applications have immensely bene-
ﬁted from omics data over the past decade (Van de Vijver et al.,
2002; Van ’t Veer et al., 2002; Hanash et al., 2008; Stratton et al.,
2009; 1000_Genomes_Project_Consortium, 2010; Hudson et al.,
2010;Meyersonetal.,2010;Pangetal.,2010;SolitandMellinghoff,
2010).
Microarrays were among the ﬁrst omics platforms to be devel-
oped, and already since their ﬁrst appearance it became clear
that microarray data would have to be integrated with other
levels of biological information in order to allow researchers
to see the “big picture” (Kohane et al., 2002). As experimental
protocols evolve with declining costs, scientists are now start-
ing to apply multiple omics platforms to analyze the same bio-
logical samples (Ideker et al., 2001; Joyce and Palsson, 2006;
Zhang et al., 2010). This type of studies will be critically use-
ful for biologists since they can measure molecular changes at
multiple levels simultaneously and get one step closer to under-
standing how biological systems work as a whole, which is one
of the primary goals of “systems biology” (Kitano, 2002; Ge
et al., 2003; Fukushima et al., 2009). As such, combining mul-
tiple omics, or “integrative omics,” holds a great potential to
revolutionize the systems-level analysis of complex biological
phenomena and several efforts are already ongoing in various
directions.
Given the enormous promise of integrative omics, ques-
tions regarding how to design experiments and jointly ana-
lyze the heterogeneous data are quickly becoming of interest.
Indeed,these new technologies generate an unprecedentedly large
amount of data and, ironically, the sheer volume makes it dif-
ﬁcult to ﬁnd a reasonable interpretation of the data. Thus the
key to successful application will depend on properly designed
experiments, statistically sound data analysis, and appropriate
interpretation of the data. In this Perspective, we review both
challenges and opportunities encountered by systems biolo-
gists,bioinformaticians,and statisticians undertaking the exciting
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and daunting task of integrating multiple heterogeneous omics
datasets.
OPPORTUNITIES OF INTEGRATIVE OMICS
BIOLOGICAL OPPORTUNITIES
Many problems in systems biology can be addressed only by inte-
grating multiple layers of biological information. For example,
numerous genetic studies using single-nucleotide polymorphism
(SNP) microarrays or high-throughput sequencing often report
hundreds of point mutations above the minimal allele frequency
as potential disease markers (Carlson et al., 2004; Manolio et al.,
2009). However, many of these markers lack the predictive power
and fail to reproduce the results across different study popula-
tions (Altshuler et al., 2008). This implies that these candidate
markers must be further prioritized with additional information
such as transcriptional or translational regulation of the gene
products affected by the mutations. Accordingly, recent genetics
research frequently explores the “genetical genomics” approach
(Li and Burmeister, 2005) to integrate population-wide SNP data
and transcriptomics data, aiming to identify expression quan-
titative trait loci (eQTL; Cheung and Spielman, 2009; Cookson
et al., 2009; Montgomery et al., 2011). The paired genotype and
gene expression data reveals the impact of genetic mutations
on transcriptional expression, which is the major mechanism
to channel genetic abnormalities into phenotypes. On a similar
front, many research articles have reported integration of copy
number data and gene expression data to cancer or adaptive evo-
lution studies (Pollack et al., 2002; Chin et al., 2006; Gresham
et al., 2008; Rancati et al., 2008). The resulting data explains how
various forms of copy number aberration, such as point ampliﬁ-
cation/deletion, segmental changes, and aneuploidy, induce gene
expression changes (Bussey et al., 2006; Stranger et al., 2007).
Besides the integration of genomic datasets, advances in tan-
dem mass spectrometry have gradually allowed us to integrate
transcriptomics data with quantitative proteomics data (Grifﬁn
et al., 2002; Cox et al., 2005; Lu et al., 2007; Fournier et al., 2010;
Pavelka et al., 2010), where proteomics data provide direct infor-
mationtoassesstheimpactof transcriptionalchangesonthegene
products.
So far we reviewed the opportunities when the same genes are
proﬁled at different levels of the primary omics. However, there
existsadditionalnetworkinformationgeneratedusingotherhigh-
throughput technologies, where the correlation between interact-
ing molecules can be explicitly modeled. These include various
assays for screening PPI (Rual et al., 2005; Gingras et al., 2007;
Costanzo et al., 2010), protein–DNA interaction data for map-
ping transcriptional regulation and epigenetics (Ren et al., 2000;
Johnson et al.,2007),post-transcriptional regulation mediated by
microRNAs (Bartel,2009;Hafner et al.,2010),and so forth. Using
thisinformation,theassociationbetweendifferentmolecules,and
the lack thereof, can be adjusted for other interacting molecules
causally linked across available omics datasets. For instance, tran-
scriptomics and metabolomics data were integrated to identify
clusters of genes and metabolites that were coordinately modu-
lated in response to speciﬁc nutritional stresses in the model plant
Arabidopsis thaliana (Hirai et al., 2004). In addition, transcrip-
tomics data were coupled with PPI networks to determine under
which circumstances protein hubs are co-expressed with their
respectiveinteractingpartners(Tayloretal.,2009)andtousejoint
expressionlevelsof genesbelongingtointeractionsubnetworksto
establish more predictive breast cancer biomarkers (Chuang et al.,
2007). Transcriptomics data were also combined with protein–
DNAinteractiondatatoinfergeneregulatorynetworks(Linetal.,
2009; Ouyang et al.,2009).
STATISTICAL OPPORTUNITIES
Integrative omics also opens an opportunity for improved statis-
tical analysis. For one,parallel omics datasets can help implement
procedurestoinfermissingdata.Manyomicsplatformsareknown
to be subject to missing observations due to lagging depth, exem-
pliﬁedbythepoorcoverageof next-generationsequencing(NGS)
in repeat-rich regions and the faltering peptide identiﬁcation
of tandem mass spectrometry in low-abundance proteins. Some
transcriptomic platforms such as microarrays are also subject to
the limitation that only a ﬁxed form of transcripts can be mea-
sured while other isoforms present in the sample go undetected.
By generating both transcriptomic and proteomic data, however,
one can perform statistical inference on the missing observations
inoneplatformusingtheobservationsintheotherplatformsince
the two data are expected to be correlated within the same bio-
logical sample. Recent endeavors to improve peptide sequencing
in tandem mass spectrometry (MS/MS) using the parallel tran-
scriptomic data are good examples of this kind (Ramakrishnan
et al., 2009; Ning and Nesvizhskii, 2010), but a more sophisti-
cated treatment of missing data using external sources is yet to be
developed.
Another important problem in the omics data analysis is the
control or estimation of false positives and false negatives, which
areincurredwhenmanystatisticaldecisionsaretobemadesimul-
taneously, i.e., the multiple testing problem. As simultaneous
hypothesis testing typically leads to excessively many selections in
omics data, currently existing multiple hypothesis testing meth-
ods are geared toward controlling the number of false positives,
as evidenced by the development of false discovery rate estima-
tion procedures (Benjamini and Hochberg, 1995; Efron et al.,
2001). Although these procedures are applicable to the analysis
of a single omics platform, the methods are easily generaliz-
able to the multivariate cases for more sophisticated hypothesis
testing when the data are available from more than a single
omics platform. Suppose that differential expression is tested at
the mRNA and protein level simultaneously. Then the hypoth-
esis testing can be performed using bivariate statistics, which is
expected to be more powerful than using two independent uni-
variate statistics, since the correlation between the two dataset
can be explicitly accounted for. In addition, the added com-
plexity in the joint testing allows differentiation of the genes
differentially expressed at both levels versus the genes regulated
at either one of the two levels only, providing additional infor-
mation to infer the underlying regulatory mechanism. Unfortu-
nately, such routines using correlated statistics have rarely been
implemented in the integrative omics data analysis so far, but
we can envision that as the number of such integrated datasets
will increase, so will the level of sophistication in the statistical
analysis.
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More importantly, the ultimate statistical opportunity in
the integrative omics data is the possibility for systems-level
probabilistic modeling of multiple data types. In practice, one
may well perform a crude form of integrative analysis,i.e.,analyze
each type of molecular level separately and aggregate the results
in a post hoc manner (Figure 1A). This approach, however, fails
to capitalize on the power of the correlated data, especially for
detecting weak yet consistent signals from multiple data sources
(Ideker et al., 2011). Hence one can start using a slightly more
sophisticated approach where the data measured at different mol-
ecular levels are modeled using multivariate probability models
(Figure 1B). As the bivariate example showed above, incorpo-
rating data from multiple molecular levels can strengthen the
statistical power, since the effects we aim to measure at one
molecular level can be adjusted by the data at the other levels.
Furthermore, the new threads of network-level information that
isbecomingincreasinglyavailable–suchastranscriptionalregula-
tory networks, genetic interaction networks, PPI networks, signal
transduction pathways and metabolic networks – allows compu-
tational biologists to integrate omics datasets at the level of nodes
andedgesof biologicalnetworks(Figure1C)andtomovebeyond
the statistical analysis under the assumption of full independence
among the different molecules. For instance, versatile statistical
techniques such as graphical models can be used in conjunc-
tion with the experimentally validated networks, which provides
the underlying backbone of the correlation structure. Such mod-
els give an efﬁcient probabilistic representation of the complex,
systems-wide molecular proﬁles and considerably improve the
statistical power in the analysis.
CHALLENGES OF INTEGRATIVE OMICS
BIOINFORMATICS CHALLENGES
The ﬁrst problem bioinformaticians face when asked to integrate,
for instance,a transcriptomics dataset and a proteomics dataset is
how to map transcript identiﬁers to protein identiﬁers. If the one-
gene-one-protein hypothesis still holds relatively well in prokary-
otes and some lower eukaryotes, the same is certainly not true
in higher organisms: genes often encode multiple transcripts by
means of alternative splicing (Graveley,2001) and transcripts can
be translated into multiple protein isoforms by means of alterna-
tive translation initiation sites (Cavener and Ray, 1991) and post-
translational modiﬁcations (Mann and Jensen, 2003). A partial
solution to this problem is provided by genome-centric databases
suchasEnsEMBL(Hubbardetal.,2002),protein-centricdatabases
such as UniProt (Apweiler et al., 2004) or more general-purposes
web services such as Babelomics (Al-Shahrour et al., 2005), that
provide coherent mappings between gene, transcript, and protein
identiﬁers. The challenge becomes even more daunting when one
starts to venture outside the central dogma of molecular biology
and attempts to integrate a transcriptomics or proteomics dataset
with a metabolomic, glycomic, or lipidomic dataset. Here, one
could take advantage of the knowledge of metabolic networks to
map enzymes involved in the synthesis or chemical conversion of
metabolites (e.g.,as provided by KEGG,Kanehisa and Goto,2000,
orReactome,Joshi-Topeetal.,2005)toestablishlinksbetweenthe
two types of datasets (Antonov et al., 2010). To this end, the sys-
tems biology markup language (SBML) represents one of the ﬁrst
andmostsuccessfuleffortsindevelopingauniﬁedlanguagetorep-
resentcomplexmodelsof interactingbiologicalmolecules(Hucka
FIGURE1|( A )Independent analysis of each data for each gene and protein.
Signiﬁcant ﬁndings are ﬁltered at each data type and aggregated by looking at
the overlap of the results. (B) Joint modeling of the bivariate distribution of
transcript and protein level data for each gene. (C) Joint modeling
incorporating the network information such as the interaction between
transcription factors and their targets.
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et al.,2003) and has been widely implemented by several software
tools. However, only a fraction of the genes in a genome typically
encodemetabolicenzymes,therestbeingstructural,regulatory,or
signal transduction proteins. Unfortunately, it is not immediately
obvioushowtoclosethesegaps.Itisthusexpectedthatintegrative
omicsdataanalysismethodswillhavetodealwiththeexistenceof
“orphan” molecules that cannot be directly mapped between the
two types of datasets.
Another bioinformatic issue is the existence of heterogeneous
repositories of primary data sources. Due to the different nature
of omics platforms, databases of microarray, NGS, proteomics,
or metabolomics experiments have been designed according to
different schemes. While it is true that each omics domain has
developeditsownstandards(suchasMIAME,Brazmaetal.,2001,
and MAGE-ML, Spellman et al., 2002, for microarray data, or
mzXML,Pedriolietal.,2004,andHUPO-PSIforproteomicsdata,
Orchard et al., 2003), the lack of well-deﬁned data standards and
of standardized nomenclature across different data repositories
makes the coherent retrieval and assembly of integrated datasets a
non-trivial task. One way to address this issue is the development
ofso-called“datawarehouses,”inwhichasigniﬁcanteffortisbeing
p u ti nb yd e v e l o p e r sa priori to store and integrate heterogeneous
primary databases into a coherent scheme by making use of inter-
mediate abstraction layers between the raw data layer and the user
access layer (Rhodes et al.,2004; Chen et al.,2010). An alternative
promisingapproachtodataintegrationinlifesciencesisofferedby
Semantic Web technologies (Splendiani et al., 2011). These tech-
nologies enable an immediate “connection” between data, which
can be easily queried across different databases. At the same time
theyallowaprecisecharacterizationof the“semantics”of thedata,
i.e., which entities are represented, and which are their relations
(Berners-Lee and Hendler,2001). Such semantic characterization
can then provide an integration of information across different
databases,which can easily cope with a variety of rapidly evolving
data sources and types (Cheung et al., 2005; Smith et al., 2007).
How widely this technology will be adopted is likely tied to how
well developers of primary omics databases will implement such
data representation methods.
STATISTICAL CHALLENGES
In addition to the bioinformatics issues, there are important sta-
tistical challenges in the integrative omics analysis. As we build
more complex models such as multivariate or inter-molecular
models, we must revisit some limitations that had plagued the
single-sourceomicsdataanalysis.First,itislikelythatthenumber
of biological samples analyzed in a typical integrative study will
remain limited, e.g., on the order of a few tens in case–control
studies and at most several replicate experiments per comparative
condition in the studies using cell lines. To address this limitation,
one can utilize efﬁcient statistical methods such as hierarchical
models,whicharecapableofpoolingstatisticalinformationacross
different molecular levels (Parmigiani et al., 2002; Sharpf et al.,
2009;JiandLiu,2010).Second,asweconsidermodelingthecorre-
lationsamonganincreasingnumberof moleculesinthestatistical





reminded that there exists a certain trade-off between the gain in
powerfromtheaddedcomplexityandthelossinspeciﬁcitydueto
a poor model ﬁt, where the latter is mainly determined by exper-
imental design issues such as the sample size. Therefore, when
complex models are employed, the interaction between model
complexity and experimental design factors must be thoroughly
evaluated in terms of strengthening sensitivity–speciﬁcity proﬁle
and reproducibility of results. In sum, it is necessary to ﬁnd the
rightbalancebetweencomplexityandmodelsparsitytodeliverthe




dataset allows researchers to explore previously uncharted ter-
ritories describing the functioning of biological systems, more
advanced data analysis methods will be required to fully trans-
latethisenormouswaveofinformationintobiologicalknowledge.
Willtheﬁeldof bioinformaticsandcomputationalbiologybeable
to keep the pace with the exponential development of omics tech-
nologies? While it is currently difﬁcult to predict whether this
gap will eventually be ﬁlled, we argue that if careful statistical
considerations are taken into account already at the experimental
design phase of a multi-omics project, then there is an opportu-
nity to build rigorous systems-level statistical models that fully
take advantage of the interdependent workings of biological mol-
ecules. Finally,to foster further advancement of the ﬁeld,it will be
critical to build integrated multi-omics statistical models that are
both reusable and easily extendable by other researchers.
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